Physician profile
Connor Mortimer
NPI 1164084802
$4,005.82
in general payments reported to CMS, 2019-2025
30 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,025 · 2022: $1,052 · 2023: $882 · 2024: $570 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $803.98 | 2021-2025 | Lifevest |
| Amgen INC. | $701.34 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $336.72 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $300.65 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.58 | 2021-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $213.12 | 2021-2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $199.34 | 2023-2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $183.35 | 2021-2023 | Uptravi, Opsumit |
| Astellas Pharma US INC | $182.40 | 2021-2022 | |
| Philips North America LLC | $146.89 | 2022-2025 | (Ck4) Mcot, Extended Holter, (Ck7) Extended Holter |
| Pfizer INC. | $123.78 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $73.92 | 2022-2023 | Camzyos |
| Cvrx, INC. | $64.31 | 2024 | Barostim Neo System |
| Terumo Medical Corporation | $59.86 | 2023-2025 | Metacross Otw, Navicross, Tr Band |
| Novo Nordisk INC | $45.42 | 2021-2023 | Ozempic |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $32.29 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $32.24 | 2023 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $31.57 | 2022-2023 | |
| Impulse Dynamics (USA) INC. | $29.88 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $24.58 | 2022-2023 | |
| Abbott Laboratories | $24.26 | 2025 | Cardiomems |
| Kowa Pharmaceuticals America, INC. | $22.86 | 2021-2022 | |
| Abiomed | $20.46 | 2025 | |
| Atricure, INC. | $18.13 | 2023 | |
| Alnylam Pharmaceuticals INC. | $16.14 | 2022 | |
| Medtronic, INC. | $15.33 | 2021 | |
| Baxter Healthcare | $14.87 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $14.82 | 2022 | |
| Boston Scientific Corporation | $14.05 | 2025 | Cds - Mct/Cem Monitoring |
| Arbor Pharmaceuticals, INC. | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Mortimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.